Sanofi Pasteur opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Sanofi Pasteur

Patent Number:
Title:
Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates Thereof
Applicant:
Opposition Date:
Jul 11, 2024
Patent Number:
Title:
Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens
Applicant:
Opposition Date:
Sep 29, 2021
Patent Number:
Title:
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses Thereof
Applicant:
Opposition Date:
Jun 8, 2021
Patent Number:
Title:
Method Of Treatment
Opposition Date:
May 18, 2021
Patent Number:
Title:
Adjuvanting Meningococcal Factor H Binding Protein
Opposition Date:
Feb 5, 2021
Patent Number:
Title:
Complexes Of Cytomegalovirus Proteins
Opposition Date:
May 7, 2020
Patent Number:
Title:
Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic Compositions
Applicant:
Opposition Date:
Oct 2, 2019
Patent Number:
Title:
Pneumococcal Polysaccharide Conjugate Vaccine
Opposition Date:
Aug 6, 2019
Patent Number:
Title:
Rapid Sterility Microassay
Applicant:
Opposition Date:
Oct 10, 2018
Patent Number:
Title:
Aluminium Compounds For Use In Therapeutics And Vaccines
Opposition Date:
Jul 10, 2018

Latest patents of Sanofi Pasteur opposed by its competitors

Patent:
Grant Date:
Jul 5, 2023
Title:
Compositions And Methods Of Immunizing Against C. Difficile
Oppositions:
1
Patent:
Grant Date:
Jun 1, 2022
Title:
Flavivirus Vaccines
Oppositions:
2
Patent:
Grant Date:
Apr 19, 2017
Title:
Stabilization Of Vaccines By Lyophilization
Oppositions:
1

Want to track Sanofi Pasteur?

Feel free to send us a message here and we will get back to you